The FDA Amendments Act of 2007
This article was originally published in SRA
Executive Summary
The Food and Drug Administration Amendments Act of 2007 renewed the mechanism under which the US FDA charges sponsors user fees. Peter Charlish reviews a new report that describes the Act's likely impact on the pharmaceutical industry.